Giberson Scott 4
4 · SAB Biotherapeutics, Inc. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
Giberson Scott
Director
Transactions
- Award
Stock Option (right to buy)
2025-12-16+150,000→ 150,000 totalExercise: $3.99Exp: 2035-12-16→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on December 16, 2026 and December 16, 2027.
- [F2]This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.